tiprankstipranks
Trending News
More News >
Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ:CVKD
US Market
Advertisement

Cadrenal Therapeutics, Inc. (CVKD) Ownership - Who Owns Cadrenal Therapeutics, Inc.?

Compare
361 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 29, 2025
xxxxxxxxxxxxx
$70356
Aug 29, 2025
xxxxxxxxxxxxx
$27984

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
614,792Insider30.04%8,023,036
500,000Insider24.43%6,525,000
50,000Insider2.44%652,500
45,633Institution2.23%595,511
43,301Institution2.12%565,078
10,673Institution0.52%139,283
3,042Institution0.15%39,698
914Institution0.04%11,928
20Institution<0.01%261

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
45,633Institution2.23%595,511
10,673Institution0.52%139,283

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
33,278Institution1.63%346,757
10,023Institution0.49%104,440
3,042Institution0.15%39,698
914Institution0.04%11,590

FAQ

Who Owns Cadrenal Therapeutics, Inc. (CVKD)?
Currently, no data Available
What percentage of Cadrenal Therapeutics, Inc. (CVKD) stock is held by institutional investors?
Currently, no data Available
What percentage of Cadrenal Therapeutics, Inc. (CVKD) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cadrenal Therapeutics, Inc. (CVKD)?
John Raymond Murphy owns the most shares of Cadrenal Therapeutics, Inc. (CVKD).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis